PRIVATE COMPANIES FOR PHASE-I STUDIES

被引:0
|
作者
LHOSTE, F
机构
[1] Service de Pharmacologie Clinique, Hôpital Necker-Enfants Malades, Paris, 75015, 161, rue de Sèvres
关键词
PHASE-I STUDY; SAFETY; HEALTHY VOLUNTEERS; PRIVATE CLINICAL LABORATORIES;
D O I
10.1111/j.1472-8206.1990.tb00084.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In France, the debate is still open regarding where phase I studies should take place. According to its strict definition, very few phase I studies are performed per year in our country. Because they are usually carried out on healthy volunteers, ethics and safety are intimately mixed in with such studies. Safety in these highly specific investigations is founded on 2 bases, first on the independence of the investigator and secondly on the laboratory environment. The economic independence and total lack of responsibility in this respect on the part of the investigator ensure that all ethical considerations including safety are focused on the personal interest of the volunteer who participates in the study.
引用
收藏
页码:S221 / S223
页数:3
相关论文
共 50 条
  • [1] PRIVATE HOSPITAL AND PHASE-I
    GALLET, M
    NONY, P
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1990, 4 : S215 - S219
  • [2] PHASE-I STUDIES WITH PYRAZOLE
    WILSON, WL
    BOTTIGLIERI, NG
    CANCER CHEMOTHERAPY REPORTS, 1962, (21): : 137 - 141
  • [3] PHASE-I STUDIES ON CHLOROZOTOCIN
    HOTH, D
    WOOLLEY, P
    GREEN, D
    MACDONALD, J
    SCHEIN, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1978, 23 (06) : 712 - 722
  • [4] PHASE-I STUDIES WITH CARBOPLATIN
    CAVALLI, F
    JOSS, R
    KAPLAN, S
    NICAISE, C
    ROZENCWEIG, M
    INVESTIGATIONAL NEW DRUGS, 1984, 2 (01) : 104 - 104
  • [5] PHASE-I STUDIES - WHAT TO MEASURE
    ROSENKRANZ, B
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1990, 4 : S59 - S62
  • [6] STATISTICAL REQUIREMENTS OF PHASE-I STUDIES
    EDLER, L
    ONKOLOGIE, 1990, 13 (02): : 90 - 95
  • [7] PHASE-I AND PHARMACOKINETIC STUDIES OF DON
    KOVACH, JS
    EAGAN, RT
    POWIS, G
    RUBIN, J
    CREAGAN, ET
    MOERTEL, CG
    CANCER TREATMENT REPORTS, 1981, 65 (11-1): : 1031 - 1036
  • [8] PHASE-I AND PHASE-II STUDIES OF VINDESINE
    VALDIVIESO, M
    CANCER TREATMENT REVIEWS, 1980, 7 : 31 - 37
  • [9] A PHASE-I TRIAL ON THE ETHICS OF PHASE-I TRIALS
    EMANUEL, EJ
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) : 1049 - 1051
  • [10] GOOD CLINICAL PRACTICES IN PHASE-I STUDIES
    DECOUSUS, H
    PERPOINT, B
    MISMETTI, P
    OLLAGNIER, M
    QUENEAU, P
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1990, 4 : S163 - S165